BAY 60-2770 activation of soluble guanylate cyclase during ischemia protects against reperfusion injury

被引：0
|
作者：
Wang, Walter Z. [1 ]
Jones, Allan W. [1 ]
Wang, Meifang [1 ]
Wang, Derek Z. [1 ]
Korthuis, Ronald J. [1 ,2 ]
机构：
[1] Univ Missouri, Columbia, MO USA
[2] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
682.3
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis
    Knorr, Andreas
    Hirth-Dietrich, Claudia
    Alonso-Alija, Cristina
    Haerter, Michael
    Hahn, Michael
    Keim, Yvonne
    Wunder, Frank
    Stasch, Johannes-Peter
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2008, 58 (02): : 71 - 80
  • [2] Efficacy of BAY 60-2770, a Soluble Guanylate Cyclase Activator, for Coronary Spasm in Animal ModelsS
    Tawa, Masashi
    Nakagawa, Keisuke
    Ohkita, Mamoru
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2024, 390 (03): : 280 - 287
  • [3] BAY 60-2770, An Activator of Soluble Guanylate Cyclase, Attenuates Postischemic Brain Injury in H129 WTMice
    Wang, Meifang
    Wang, Walter
    Wang, Derek
    Jones, Allan
    Korthuis, Ronald
    FASEB JOURNAL, 2015, 29
  • [4] Different sensitivities of porcine coronary arteries and veins to BAY 60-2770, a soluble guanylate cyclase activator
    Tawa, Masashi
    Nakagawa, Keisuke
    Ohkita, Mamoru
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2025, 157 (01) : 1 - 7
  • [5] Preconditioning with Bay 60-2770, An Activator of Soluble Guanylate Cyclase, Attenuates Myocardial Infarction in eNOS Knockout Mice
    Wang, Meifang
    Wang, Derek Z.
    Jones, Allan W.
    Zuidema, Mozow Y.
    Wang, Walter Z.
    Korthuis, Ronald J.
    FASEB JOURNAL, 2013, 27
  • [6] EFFECTS OF A SOLUBLE GUANYLATE CYCLASE ACTIVATOR, BAY 60-2770, ON NEUROGENIC LOWER URINARY TRACT DYSFUNCTION IN MICE WITH SPINAL CORD INJURY
    Gotoh, D.
    Saito, T.
    Kurobe, M.
    Igarashi, T.
    Singh, N.
    Miyake, M.
    Torimoto, K.
    Fujimoto, K.
    Yoshimura, N.
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 : S274 - S275
  • [7] Therapeutic effects of a soluble guanylate cyclase activator, BAY 60-2770, on lower urinary tract dysfunction in mice with spinal cord injury
    Gotoh, Daisuke
    Saito, Tetsuichi
    Karnup, Sergei
    Morizawa, Yosuke
    Hori, Shunta
    Nakai, Yasushi
    Miyake, Makito
    Torimoto, Kazumasa
    Fujimoto, Kiyohide
    Yoshimura, Naoki
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2022, 323 (04) : F447 - F454
  • [8] Pharmacological characterisation of the relaxation induced by the soluble guanylate cyclase activator, BAY 60-2770 in rabbit corpus cavernosum
    Estancial, Camila S.
    Rodrigues, Renata L.
    De Nucci, Gilberto
    Antunes, Edson
    Monica, Fabiola Z.
    BJU INTERNATIONAL, 2015, 116 (04) : 657 - 664
  • [9] Soluble Guanylate Cyclase Modulators, BAY 41-2272 and BAY 60-2770, Inhibit Human and Rabbit Prostate Contractility
    Calmasini, Fabiano B.
    Alexandre, Eduardo C.
    Silva, Fabio Henrique
    De Nucci, Gilberto
    Antunes, Edson
    D'Ancona, Carlos A.
    Monica, Fabiola Z.
    UROLOGY, 2016, 94 : 312 - U392
  • [10] Cardioprotective effects of PKG activation by soluble GC activator, BAY 60-2770, in ischemia-reperfusion-injured rat hearts
    Lee, Kyung Hye
    Lee, So-Ra
    Cho, Haneul
    Woo, Jong Shin
    Kang, Jung Hee
    Jeong, Yun-Mi
    Cheng, Xian Wu
    Kim, Woo-Shik
    Kim, Weon
    PLOS ONE, 2017, 12 (07):
12345